Sanofi Group
Operating companyHQ: France
Not counted above: 6 file-access requests (R. 262.1(b) RoP), where someone asked to read a case file. View
Sanofi Group has been party to 33 Unified Patent Court cases, 22 times as claimant and 11 times as respondent. The most recent on record is UPC CoA 22/2026 at the Court of Appeal. Its most recent decision on the merits was in UPC CFI 146/2024 at the Munich Local Division on 12 December 2025: patent revoked.
- 2026-02-12UPC CoA 22/2026Court of Appeal—Sanofi Mature IP v STADAPHARM GmbH
- 2026-02-12UPC CoA 23/2026Court of Appeal—Sanofi Mature IP v Reddy Pharma SAS
- 2026-02-12UPC CoA 24/2026Court of Appeal—Sanofi Mature IP v Zentiva France
- 2026-02-12UPC CoA 25/2026Court of Appeal—Sanofi-Aventis Deutschland GmbH v STADA Arzneimittel AG
- 2026-02-12UPC CoA 26/2026Court of Appeal—Sanofi Mature IP v betapharm Arzneimittel GmbH
- 2026-02-12UPC CoA 27/2026Court of Appeal—Sanofi Mature IP v Zentiva, k.s.
- 2026-01-12UPC CFI 106/2026Munich LDCosts onlySanofi Mature IP v STADAPHARM GmbH
- 2026-01-12UPC CFI 108/2026Munich LD—STADA Arzneimittel AG v Sanofi-Aventis Deutschland GmbH
- 2026-01-12UPC CFI 92/2026Munich LD—Sanofi Mature IP v Reddy Pharma SAS
- 2026-01-12UPC CFI 98/2026Munich LD—Sanofi Mature IP v Zentiva France